Migueles S A, Sabbaghian M S, Shupert W L, Bettinotti M P, Marincola F M, Martino L, Hallahan C W, Selig S M, Schwartz D, Sullivan J, Connors M
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Department of Transfusion Medicine, Clinical Center, and Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2709-14. doi: 10.1073/pnas.050567397.
A unique cohort of HIV-1-infected long term nonprogressors (LTNP) with normal CD4(+) T cell counts and <50 copies/ml of plasma were prospectively recruited for study. HLA typing revealed a dramatic association between the HLA B5701 class I allele and nonprogressive infection [85% (11 of 13) vs. 9.5% (19 of 200) in progressors; P < 0. 001]. Antigen-specific CD8(+) T cells were enumerated by flow cytometric detection of intracellular IFN-gamma in response to HIV antigens and HLA B57-gag tetramer staining. No quantitative differences in the total HIV-specific CD8(+) T cell responses were observed between B57(+) LTNP and five B57(+) progressors (P = 0.4). Although similar frequencies of peptide specific CD8(+) T cells were also found, the gag-specific CD8(+) T cell response in the LTNP group was highly focused on peptides previously shown to be B57-restricted. These findings indicate that, within this phenotypically and genotypically distinct cohort, a host immune factor is highly associated with restriction of virus replication and nonprogressive disease. They also strongly suggest a mechanism of virus specific immunity that directly operates through the B5701 molecule. Further characterization of qualitative differences in the virus-specific responses that distinguish HLA B*57(+) LTNP from progressors may ultimately define mechanisms of effective immune mediated restriction of virus replication.
我们前瞻性招募了一组独特的HIV-1感染长期不进展者(LTNP),其CD4(+) T细胞计数正常且血浆病毒载量<50拷贝/毫升进行研究。HLA分型显示HLA B5701 I类等位基因与非进展性感染之间存在显著关联[进展者中为85%(13例中的11例)对9.5%(200例中的19例);P<0.001]。通过流式细胞术检测细胞内IFN-γ对HIV抗原的反应以及HLA B57-gag四聚体染色来计数抗原特异性CD8(+) T细胞。在B57(+) LTNP和五名B57(+)进展者之间,未观察到总HIV特异性CD8(+) T细胞反应的定量差异(P = 0.4)。虽然也发现了相似频率的肽特异性CD8(+) T细胞,但LTNP组中gag特异性CD8(+) T细胞反应高度集中于先前显示受B57限制的肽。这些发现表明,在这个表型和基因型不同的队列中,一种宿主免疫因子与病毒复制受限和非进展性疾病高度相关。它们还强烈提示了一种通过B5701分子直接起作用的病毒特异性免疫机制。进一步表征区分HLA B*57(+) LTNP与进展者的病毒特异性反应的定性差异,最终可能确定有效免疫介导限制病毒复制的机制。